Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective CABG?

NCT01295567 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01295567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01295567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective CABG?
Lead sponsor
Radboud University Medical Center
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2012
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, ischemic heart disease